AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2016

May 5, 2016

30339_dirs_2016-05-05_ab50d8df-0fe4-454f-9fbd-8187f2e27683.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-05-03

Reporting Person: WEILAND JOHN H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-03	Common Stock	A	2262.0000	$0.0000	Acquired	41449.9584	Direct

Footnotes

F1: These shares of restricted stock units will vest in full after 12 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.